SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Metcalf who wrote (39)8/23/1996 12:41:00 PM
From: Joe Stephenson   of 1321
 
I am aware that other companies are also working on PDT. I follow QLTIF most closely and from what I read, they are further along (and in some cases significantly further along) the approval process than other companies. Do you know if the stock of PCYC and any other companies rose last December when QLTIF received their first (and so far the only) FDA approval for PDT? As has been noted, there is a real advantage in the biotech sector for being the first to market.

Would you please enlighten me on Gadolite. I assume their pending approval is with the FDA. Do you also know if PCYC or any other companies have received regulatory approval for PDT in other countries? Sometimes, as with QLTIF, approval abroad comes before the FDA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News